SEC Form 4 research
| Issuer | Karyopharm Therapeutics Inc. |
|---|---|
| Tickers | KPTI |
| Reporting owners | 42 |
| Officers and directors | 22 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Abate Kristin | S | 378 | $1.19 | Not reported |
| 2026-09-02 | 2026-09-01 | Abate Kristin | S | 19 | $2.02 | Not reported |
| 2026-07-30 | 2026-07-28 | Poulton Stuart | S | 189 | $7.1 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.